Results 11 to 20 of about 25,658,089 (295)

Topoisomerase I inhibitors: camptothecins and beyond [PDF]

open access: yesNature Reviews Cancer, 2006
Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme. It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived. As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromolecular ...
Pommier, Yves, Yves Pommier
openaire   +3 more sources

PROSPECTS FOR SEARCHING MULTITARGET TOPOISOMERASE INHIBITORS WITH ANTITUMOR PROPERTIES [PDF]

open access: yesСибирский онкологический журнал, 2019
Purpose of research: to identify the prospects of search for new antitumor non-camptothecin inhibitors of topoisomerase I/II among the various chemical compounds based on the analysis of side effects.Material and Methods.
M. I. Treshchalin   +2 more
doaj   +2 more sources

Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays. [PDF]

open access: yesSci Rep, 2018
Topoisomerases are important targets for antibacterial and anticancer therapies. Bacterial topoisomerase I remains to be exploited for antibiotics that can be used in the clinic.
Sandhaus S, Chapagain PP, Tse-Dinh YC.
europepmc   +2 more sources

Combination of PARPi and topoisomerase I inhibitors is highly effective in olaparib-resistant ovarian cancer [PDF]

open access: yesExperimental Hematology & Oncology
High-grade serous ovarian carcinoma (HGSOC) often shows an initial response to poly (ADP-ribose) polymerase inhibitors (PARPi) such as olaparib, particularly in tumors with defects in homologous recombination (HR), but resistance to these drugs is a ...
M. Chiappa   +10 more
doaj   +2 more sources

Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products [PDF]

open access: yesMarine Drugs, 2017
Currently, DNA topoisomerase I (Topo I) inhibitors constitute a family of antitumor agents with demonstrated clinical effects on human malignancies. However, the clinical uses of these agents have been greatly limited due to their severe toxic effects ...
Lan-Ting Xin   +10 more
doaj   +2 more sources

Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies [PDF]

open access: yesMolecular Medicine
Cervical cancer represents a critical global health burden, particularly among women in countries with limited healthcare infrastructure, where it accounts for a substantial proportion of cancer-related morbidity and mortality.
Yashaswini Reddy   +6 more
doaj   +2 more sources

Encapsulation and Enhanced Delivery of Topoisomerase I Inhibitors in Functionalized Carbon Nanotubes [PDF]

open access: yesACS Omega, 2018
Sieun Chae   +10 more
doaj   +2 more sources

Fluoroquinolones as HIV-1 integrase, topoisomerase I and II inhibitors.

open access: yes, 2023
Fluoroquinolones as HIV-1 integrase, topoisomerase I and II inhibitors.
Kulsoom Ghulam Ali (14992580)   +6 more
core   +1 more source

Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer

open access: yesThoracic Cancer, 2022
Background Small cell lung cancer (SCLC) is a highly aggressive disease with a poor prognosis. Although most patients initially respond to topoisomerase inhibitors, resistance rapidly emerges.
Miwako Omori   +8 more
doaj   +1 more source

MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA [PDF]

open access: yes, 2012
Topoisomerase II creates a double-strand break intermediate with topoisomerase covalently coupled to the DNA via a 5'-phosphotyrosyl bond. These intermediate complexes can become cytotoxic protein-DNA adducts and DSB repair at these lesions requires ...
Caroline A. Austin   +32 more
core   +1 more source

Home - About - Disclaimer - Privacy